"you have to be Mentally Retarded to short a .63 cent Biotech stock"
Hi young Lady, The recent Filings with SEC that are being treated with confidentiality in relation to Dealings with Sanofi? Answer: The word in my Biotech circle is that Sanofi is in discussions with GNBT for a partnership for Oralyn TM after phase 3 results come in. Personally, I would not be shocked if Sanofi makes a move for Gnbt in coming weeks. The most exciting part of being a long in GNBT is that any given day Gnbt can go 10 times what it is trading at right now. I also believe that Shorts will be wiped out complete on this one!
Son, You was not even a twinkle in your Mama's eyes I have been in and out of Gnbt Since 2005 and been investing in Bio Techs since the 60's and I shook hands with the chief Scientific Advisor of Gnbt who happens to be nick named Grand father of Bio Technology.)